Category: In Vitro Diagnostics
In Vitro Diagnostics market research reports by Kalorama Information
-
IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests
The global volume of IVD procedures is forecast to increase 7.9% annually to 111.3 billion in 2025. The same timeframe will see worldwide sales of IVD products expanding 5.4% per year to $95 billion. Blood glucose monitoring activities will account for approximately 76% of testing volume and about $ ... Read More
-
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends
COVID-19 Testing Market Update 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently. Hundreds of test p ... Read More
-
The Market and Future Potential for Molecular Point of Care
The Market and Future Potential for Molecular Point of Care This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies s ... Read More
-
The Worldwide Market for In Vitro Diagnostics, 13th Edition
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2025 for defined segments of the IVD market and various sub-segments, including: COVID Testing – Immunoassays and Molecular Molecular Assays (Inf ... Read More
-
Molecular Diagnostics Markets in The COVID-19 Era
Molecular Diagnositcs Markets in The COVID-19 Era Now more than ever, molecular diagnostics are the most important part of in vitro diagnostics. Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for molecular diagnostics in all major s ... Read More
-
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment. Especially in oncology, companion diagnostics are ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
Emerging Infectious Disease Diagnostics: Markets and Trends Why is it important to examine the world of emerging infectious diseases? In a 2015 TED Talk, Microsoft creator Bill Gates warned that there was a lack of preparation for a viral epidemic. He predicted that it would be “microbes, not missil ... Read More
-
Hematology and Coagulation Markets (Lab-based and Decentralized Markets)
Hematology and Coagulation Markets (Lab-based and Decentralized Markets) Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in ord ... Read More
-
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of ... Read More
-
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current C ... Read More
-
Artificial Intelligence Markets in IVD
Artificial Intelligence Markets in IVD The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC) This report represents the 7th edition of a fast-growing and competitive category of t ... Read More
-
The Market and Future Potential for Molecular Point of Care
The Market and Future Potential for Molecular Point of Care This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies s ... Read More
-
Molecular Cancer Diagnostics Market
Molecular Cancer Diagnostics Market The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the ... Read More
-
Clinical Laboratory Services Market, 5th Edition
Clinical Laboratory Services Market, 5th Edition Clinical laboratories are an essential part of the health industry. The market for laboratory services ranges from routine blood work to esoteric laboratory-developed tests (LDTs). In addition to diagnosing patients, clinical lab testing may be perf ... Read More
-
CAR-T Cell Therapy Market Review
CAR-T Cell Therapy Market Review CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer d ... Read More
-
Current IVD Market Trends
Current IVD Market Trends This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Sel ... Read More
-
The World Market for HbA1c Tests
The World Market for HbA1c Tests Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-test ... Read More
-
IVD Test Procedure Volumes, 2019-2024
IVD Test Procedure Volumes, 2019-2024 In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-20 ... Read More
-
The Worldwide Market for In Vitro Diagnostic Tests: 12th Edition
The Worldwide Market for In Vitro Diagnostic Tests: 12th Edition What is the Size of the 2019 IVD Market? How fast will the market grow? What companies stand to gain? Kalorama has answered these questions for readers for two decades. Now in its 12th edition, this Kalorama Information report, The Wor ... Read More
-
The World Market for Biomarkers (Cardiac Markers [cTn, HscTn, Acute CK-MB/BNP, Others], Tumor Markers [PSA, CEA, CA 125, AFP, PSA Rapid, Others], Coagulation Markers [PT/INR, D-dimer], Infectious Disease Markers [by Disease], Immunological Disease Markers [Autoimmune/Allergy], Neurological Markers, C-Reactive Protein and Other Markers)
The World Market for Biomarkers (Cardiac Markers [cTn, HscTn, Acute CK-MB/BNP, Others], Tumor Markers [PSA, CEA, CA 125, AFP, PSA Rapid, Others], Coagulation Markers [PT/INR, D-dimer], Infectious Disease Markers [by Disease], Immunological Disease [Autoimmune/Allergy], Neurological Markers, C-Reacti ... Read More
-
Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)
Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests) Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examine ... Read More
-
Mergers and Acquisitions in the IVD Market
Mergers and Acquisitions in the IVD Market In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing mar ... Read More
-
The World Molecular Diagnostics Market, 8th Edition
The World Molecular Diagnostics Market, 8th Edition Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including tr ... Read More
-
Syndromic Testing Markets
Syndromic Testing Markets Saving sample volume, cutting down provider time, reducing costs, improving outcomes, these are goals of the healthcare system, and they are well suited to a test that can identify more than a single pathogen. It has been thought that numerous pathogens tested directly from ... Read More
Research Assistance
